Good morning to you all. Please find enclosed a summary of the breaking small-cap and micro-cap financial news we highlighted on AGORACOM Small Cap TV this morning. It’s November 22nd 2010, and we’ve found 3 great press releases to report on at the open. Another great day for small-cap and micro-cap financial news. To watch the show live every morning at 9:30 AM, visit our front page.

China Agri-Business Reports Substantial Growth in the Third Quarter

China Agri-Business, Inc. ("China Agri" or the "Company," OTC: CHBU), a manufacturer and distributor of organic agricultural application products in China, announced its operation results for the three months ended September 30, 2010.

Highlights For Three Months Ended September 30, 2010

• Total sales increased 471% to $3,530,563 in the third quarter 2010 compared to $617,457 in the third quarter of 2009.
• Sales of internally made products increased 192% to $1,800,843 compared to $617,457 in the third quarter of 2009
• Net income increased 261% to $895,984 in the third quarter 2010 compared to $247,818 in the third quarter of 2009
• Earnings per common share increased to $0.07 in the third quarter 2010compared to $0.02 in the third quarter of 2009

About China Agri-Business, Inc.

China Agri-Business, Inc., through its operating company in China, Shaanxi Xinsheng Centennial Agriculture and Technology Co., Ltd., manufactures and sells non-toxic fertilizer, bactericide, and fungicide products used for farming in China. Crops grown with Xinsheng's products are eligible to qualify for the "AA Green Food" rating administered by the China Green Food Development Center, an agency under the jurisdiction of the Ministry of Agriculture of the People's Republic of China (however, our products themselves do not bear the "AA green food" designation).

Last Trade: 1.02 52 Week: 1.17 – 0.271Market Cap: 13.22 Million

Weikang Bio-Technology Signs 3 New Agent Contracts - $15 Million in Annual Sales

Weikang Bio-Technology Group Co., Inc. (OTC Bulletin Board:WKBT.ob - News) ("Weikang" or the "Company"), a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced it has added three new sales agents in southwest and south central China.

Weikang has signed two provincial agent contracts and one municipal agent contract in Guangxi, Hunan and Xiangtan. The new sales agents began working with Weilang at the beginning of October and have already contributed to $1.4 million in sales to fourth quarter 2010 revenue. The two provincial contracts are expected to add $6 million each to annual sales and the municipal contract is expected to add or $3 million in annual sales. The products will be sold through a variety of retail outlets including pharmacies and nutritional stores.

About Weikang Bio-Technology Group Co., Inc.

Weikang Bio-Technology Group Co., Inc. is principally engaged in developing, manufacturing and distributing Traditional Chinese Medicine (TCM), and health and nutritional supplements in China, in compliance with requisite Chinese licenses and approvals. The Company is also expanding its business scope to develop, manufacture and distribute Chinese herbal extract products and GMP certified western prescription and OTC pharmaceuticals through its acquisition of Tianfang.

Last Trade: 3.2252 Week: 6.99 – 1.90Market Cap: 90.37 Million